Derek Hennecke is a veteran biotech entrepreneur and board member with over 30 years of experience in the CDMO industry. His mission is to support the biotech revolution and create value for patients, customers, and investors. In addition to his Board work, Derek previously held leadership positions at DSM and was the Founder and CEO of Xcelience, which he eventually sold to Capsugel Lonza in 2016.
Xcelience was a Florida-based CDMO that specialized in preformulation, micronization, analytical services, formulation development, cGMP manufacturing, and more. His extensive expertise in pharma and cell therapy makes for an insightful conversation that founders can learn from.
.png)
Building & Scaling Xcelience | Buy-Side vs. Sell-Side of M&A | The Importance of Continuous Learning | Transition into Investing & Board Member Work
Starting an Operations Role in Egypt | The Importance of Teamwork | Moving into Biologics & Overseeing GMP Operations | Buying a Business & Founding Xcelience
Taking Risks and Jumping for the Right Opportunity | The Willingness To Do, Opens Doors | Your Job is More than the Products It is Producing | Building Trust in Other Countries
Sales Means Having Two Ears and One Mouth | The Support of a Partner Can Make or Break a Career | Skip the MBA
Start listening to TBSP episodes on your favorite platform. Subscribe to stay up to date on new episodes.
